Crossmark

Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study

Crossref DOI link: https://doi.org/10.1186/s13063-018-3115-4

Published Online: 2019-01-09

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Yiyi

Cao, Xiaomin

Zang, Wensi

Tan, Shanyong

Ou, Chun-quan

Shen, Xiaoyan

Gao, Tianming

Zhao, Lianxu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81329003)

National Natural Science Foundation of China (31430032)

National Natural Science Foundation of China (81671356)

the Program for Changjiang Scholars and Innovative Research Team in University (IRT_16R37)

the Guangzhou Science and Technology Project (201707020027)

the Natural Science Foundation of Guangdong (2016A030310396)

Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education (LC2016PY031)
License Information

Text and Data Mining valid from 2019-01-09
More Information

Article History

Received: 28 October 2017

Accepted: 7 December 2018

First Online: 9 January 2019

Ethics approval

: The Medical Ethics Committee of Zhujiang Hospital, Southern Medical University, China (2017-SJNK-001).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations (Addtional file ).

Document is current

Any future updates will be listed below